Current reports

Estimated revenues for the third quarter and 9 months of the 2025 financial year

Information on the conclusion of a significant sales agreement

Information on the conclusion of a significant sales agreement

Operational highlights of the medical devices, IT solutions and services sales segment

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a neurosurgery system MRgFUS

Receipt of a notification pursuant to Article 69 of the Act on Public Offerings—change in the percentage of the Company’s total voting rights

Notice of a transaction by a person fulfilling management duties

Notice regarding the completion of the accelerated bookbuilding process for Synektik SA shares

Announcement regarding the commencement of the accelerated bookbuilding process for Synektik SA shares

Information on the conclusion of a significant sales agreement

Preliminary estimate of changes to the Issuer’s statement of comprehensive income and equity following the spin-off of Syn2bio SA

Information on the conclusion of a significant agreement on the sale of a robotic system

Estimated revenues for the first half of the 2025 financial year

Information on the conclusion of a significant agreement on the sale of a robotic system

Operational highlights of the medical devices, IT solutions and services sales segment

Approval by the Registry Court of the Issuer’s division

Notification of transactions on the Company's shares

Notification of transactions on the Company's shares

Information on the conclusion of a significant agreement on the sale of a robotic system

List of shareholders holding at least 5% of the total number of votes at the Extraordinary Shareholder Meeting on 19 March 2026

Resolutions adopted by the Extraordinary Shareholder Meeting of Synektik SA on 19 March 2026

Information on the conclusion of a significant agreement on the sale of robotic systems

Information on the conclusion of a significant agreement on the sale of robotic systems

Announcement on Convening an Extraordinary Shareholder Meeting to be held on 19 March 2026

Second notification of intent to carry out a division of Synektik SA

Correction to the interim condensed consolidated financial statements in Q1 2025

First notification of intent to carry out a division of Synektik SA

Expansion of cooperation under the distribution agreement with Intuitive Surgical

Information on the conclusion of a significant agreement on the sale of robotic systems

Information on the conclusion of a significant agreement on the sale of robotic systems

List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 20 January 2026

Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 20 January 2026 (correction published on 21.01.2026)

Dividend payout resolution

Additional documentation for the Ordinary Shareholder Meeting of SYNEKTIK SA

Information on the conclusion of a significant agreement on the sale of robotic system

Operational highlights of the medical devices, IT solutions and services sales segment

Information on the conclusion of a significant agreement on the sale of robotic system

Partnering agreement with HistoSonics for exclusive distribution of Edison histotripsy systems

Announcement on Convening the Ordinary Shareholder Meeting to be held on 20 January 2026

Information on the conclusion of a significant agreement on the sale of a robotic system

Management Board’s recommendation to pay a dividend for the 2024 financial year

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant sales agreement

Information on the conclusion of a significant agreement

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Dates of publication of periodic reports

Receipt of notification pursuant to Article 69 of the Act on Public Offering – change in the status of ownership of the Issuer's shares

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale a robotic system

Information on the conclusion of a significant sales agreement

Operational highlights of the medical devices, IT solutions and services sales segment

Information on the conclusion of a significant agreement on the sale a robotic system

Appointment of a Management Board Member

Additional information pertaining to the conclusion of a significant agreement on the sale of a robotic system – Supplement to current report no. 48/2025

Information on the conclusion of a significant agreement on the sale a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement to license the production of Glunektik

Information on the conclusion of a significant agreement on the sale of a robotic system

Auditor's report on the audit of the Division Plan

Information on the conclusion of a significant agreement

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant sales agreement

Information on the conclusion of a significant agreement

Information on the conclusion of a significant sales agreement on the sale of a robotic system

Agreeing and adoption of the Issuer's division plan

Information on the conclusion of a significant sales agreement

Operational highlights of the medical devices, IT solutions and services sales segment

Notification of transactions on the Company's shares

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant sales agreement

Notification of transactions on the Company's shares

Operational highlights of the medical devices, IT solutions and services sales segment

Information on the conclusion of a significant agreement on the sale of a robotic system

Notification of transactions on the Company's shares

Information on the conclusion of a significant sales agreement

Receipt of a notice under the procedure envisaged by art. 69 of the Act on Offerings - change in the percentage of the total number of votes in the Company

Receipt of a notice under the procedure envisaged by art. 69 of the Act on Offerings - change in the percentage of the total number of votes in the Company

Notification of transactions executed by a person discharging managerial responsibilities

Correction to ESPI Report 17/2025 - Notification of transactions executed by a person discharging managerial responsibilities

Information on the completion of the book-building process for Synektik SA shares

Information on the commencement of the book-building process for Synektik SA shares

Information on the conclusion of a significant agreement on the sale of a robotic system

Estimated revenue in Q1/ FY 2024

List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 22 January 2025

Constitution of the Company’s Supervisory Board

Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 22 January 2025

Appointment of Supervisory Board Members

Dividend payout resolution

Additional documentation for the Ordinary Shareholder Meeting of SYNEKTIK SA

Declaration on not exercising the personal right to appoint Supervisory Board members

Submission of candidates to the Issuer’s Supervisory Board

Information on the conclusion of a significant agreement on the sale of a robotic system

Acquisition of shares in a company holding medical IT software

Operational highlights of the medical devices, IT solutions and services sales segment

Information on the conclusion of a significant agreement on the sale of a robotic system

Notification of transactions on the Company's shares

Announcement on Convening the Ordinary Shareholder Meeting to be held on 22 January 2025

Management Board’s recommendation to pay a dividend for the 2023 financial year

Appointment of the Management Board Members for another term of office

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Modification of the date of publication of the standalone financial statements and the consolidated financial statements for the 2023 financial year

Selection of a Member to the Supervisory Board’s Nomination and Compensation Committee

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement

Information on the conclusion of a significant sales agreement

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement

Dates of publication of periodic reports

Filling the vacancy on the Audit Committee and election of the Audit Committee Chairman

Operational highlights of the medical devices, IT solutions and services sales segment

Extension of the distribution agreement with Intuitive Surgical

Information on the conclusion of a significant sales agreement

List of shareholders with at least 5% of the total number of votes at the Extraordinary Shareholder Meeting held on 8 October 2024

Text of the resolutions adopted at the Extraordinary Shareholder Meeting of Synektik SA on 8 October 2024

Appointment of a Supervisory Board member

Information on the conclusion of a significant agreement on the sale of a robotic system

Proposing a candidate to the Issuer’s Supervisory Board 

Information on the conclusion of a significant agreement

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement on the sale of a robotic system

Announcement on Convening an Extraordinary Shareholder Meeting to be held on 8 October 2024

Notification of transactions executed by a person discharging managerial responsibilities

Resignation of a Synektik SA Supervisory Board Member

Information on the conclusion of a significant sales agreement

Information on the conclusion of a significant agreement on the sale of a robotic system

Notification of transactions executed by a person discharging managerial responsibilities

Annex to the distribution agreement with Intuitive Surgical Sarl

Information on the conclusion of a significant agreement

Operational highlights of the medical devices, IT solutions and services sales segment

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant sales agreement

Information on the conclusion of a significant agreement

Partnership agreement for exclusive distribution of Symani microsurgery robots

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant agreement

Contract for the exclusive distribution of Qure.ai’s global artificial intelligence solution to assess the results of radiology tests in Poland, the Czech Republic and Slovakia

Information on the conclusion of a significant agreement on the sale of a robotic system

Operational highlights of the medical devices, IT solutions and services sales segment

Information on the conclusion of a significant agreement on the sale of a robotic system

Information on the conclusion of a significant sales agreement

Notification of transactions executed by a person discharging managerial responsibilities

Information on the conclusion of a significant sales agreement

List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 26 February 2024

Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 26 February 2024

Dividend payout resolution

Information on the conclusion of a significant agreement on the sale of a robotic system

Notification of transactions executed by a person discharging managerial responsibilities

Information on the conclusion of a significant sales agreement

Expansion of a cooperation agreement

Notification of transactions executed by a person discharging managerial responsibilities

Information on the conclusion of a significant agreement on the sale of a robotic system

Estimated revenue in Q1 2023

Obtaining a patent for a cardiac marker in Japan

Auditor's assessment of Synektik's report on payments of the Management Board and Supervisory Board for FY2022

Report on payments of the Management Board and Supervisory Board for FY2022

Completion of documentation to be discussed at the Ordinary General Meeting of SYNEKTIK SA

Corrected draft resolutions attached to ESPI report 5/2024/K

Correction of current report ESPI 5/2024 - Announcement on convening the Ordinary General Meeting of Shareholders for February 26, 2024

Announcement on the convening of the Ordinary General Meeting of Shareholders for February 26, 2024

Recommendation of the Management Board on the payment of dividends for FY2022

Establishment of a bank guarantee for a counterparty

Update on the cardiotracer project

Selected operating data of the medical devices, IT solutions and services sales segment